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2352-345XSUMMARY
Our results show that LGR5 is induced during deﬁnitive
endoderm differentiation, LGR receptors are functionally
required for deﬁnitive endoderm induction, and that they
function to potentiate WNT signaling during this process.
BACKGROUND & AIMS: The Lgr family of transmembrane
proteins (Lgr4, 5, 6) act as functional receptors for R-spondin
proteins (Rspo 1, 2, 3, 4), and potentiateWnt signaling in different
contexts. Lgr5 is arguably the best characterized of the Lgr family
members in a number of adult and embryonic contexts in mice.
However, the function of LGR family members in early embryonic
development is unclear, and has not been explored during human
development or tissue differentiation in detail.
METHODS: We interrogated the function and expression of
LGR family members using human pluripotent stem
cell–derived tissues including deﬁnitive endoderm, mid/
hindgut, and intestinal organoids. We performed embryonic
lineage tracing in Lgr5-GFP-IRES-CreERT2 mice.
RESULTS: We show that LGR5 is part of the human deﬁnitive
endoderm (DE) gene signature, and LGR5 transcripts are
induced robustly when human pluripotent stem cells are
differentiated into DE. Our results show that LGR4 and 5
are functionally required for efﬁcient human endoderm in-
duction. Consistent with data in human DE, we observe Lgr5
reporter (eGFP) activity in the embryonic day 8.5 mouse
endoderm, and show the ability to lineage trace these cells into
the adult intestine. However, gene expression data also suggest
that there are human–mouse species-speciﬁc differences at
later time points of embryonic development.
CONCLUSIONS: Our results show that LGR5 is induced during
DE differentiation, LGR receptors are functionally required
for DE induction, and that they function to potentiate WNT
signaling during this process. (Cell Mol Gastroenterol Hepatol
2016;2:648–662; http://dx.doi.org/10.1016/j.jcmgh.2016.06.002)
Keywords: Pluripotent Stem Cells; Endoderm; LGR5; WNT;
Organoid; Intestine.
nt signaling is a critical signaling pathway in ahttp://dx.doi.org/10.1016/j.jcmgh.2016.06.002
Wbroad number of developmental, homeostatic,
and disease contexts.1–4 Recent work has shown theimportance of secreted R-spondin proteins (Rspo 1–4) and
their Lgr receptors (Lgr 4, 5, and 6) as important modula-
tors of the Wnt signaling pathway that act to potentiate Wnt
signaling.5–11 For example, R-spondin ligands and Lgr re-
ceptors are all required for tight regulation of the crypt base
columnar intestinal stem cells of the adult mouse epi-
thelium.2,7,12–16 In adult intestinal stem cells, Lgr4 and Lgr5
are redundantly required for stem cell maintenance,7
whereas in the fetal murine intestine, it appears that Lgr5
is dispensable, although Lgr4 is essential for growth.17–19
However, despite our increasing understanding of the
importance of Rspo/Lgr signaling in the intestine during
mouse development and adult homeostasis, nothing is
known about the functional role for LGR genes during hu-
man endoderm differentiation and little is known about
expression in human tissues.
In this study, we used several methods to show that LGR5
is induced robustly in human embryonic stem cell–derived
deﬁnitive endoderm (DE) and is one of the most highly up-
regulated genes in the DE gene signature. Analysis of chro-
matin immunoprecipitation sequencing (ChIPseq) data show
that LGR5 is bound directly by b-catenin upon WNT stimu-
lation in human embryonic stem cells (hESCs) and that
H3K27ac is increased at the LGR5 locus during DE differen-
tiation. Genetic lineage tracing in the embryonic day (E)8.5
mouse embryo supports human expression data that Lgr5 is
expressed in the early endoderm. We also examined the
expression of all 3 LGR family members, LGR4, LGR5, and
LGR6, during endoderm lineage speciﬁcation, hindgut in-
duction, and differentiation into intestinal organoids, and we
compared expression in the human fetal intestine and mouse
embryonic intestine, where we found notable species-
speciﬁc differences. In human tissues, LGR5 was expressed
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human fetal intestine, whereas LGR4 was expressed at lower
levels, and LGR6 was undetectable. In contrast, in mice, Lgr4
and Lgr6 were more abundant than Lgr5. Functionally, our
data show that RSPO/LGR signaling synergizes with WNT
signaling during human endoderm induction, and short
hairpin RNA (shRNA) knockdown of either LGR4 or LGR5
signiﬁcantly impairs the ability of hESCs to differentiate into
DE. Taken together, our work details a previously unchar-
acterized functional role for LGR4 and LGR5 during human
DE differentiation, and highlights species-speciﬁc gene
expression differences between humans and mice during
intestine development.
Materials and Methods
hESC Cell Lines, Human Tissue, and Mice
hESCs. All work with hESCs was reviewed and approved by
the University of Michigan human pluripotent stem cell
research oversight committee. The hESC cell line H9 (WA09;
National Institutes of Health stem registry 0062) was ob-
tained from the WiCell Research Institute (Madison, WI).
Karyotypically normal cell lineswereused for all experiments.
Human tissue. De-identiﬁed human intestinal tissue was
obtained from the University of Washington Laboratory of
Developmental Biology, and was approved by the University
of Michigan institutional review board.
Animal use. All mouse work was reviewed and approved
by the University Committee on Use and Care of Animals
(PRO00005809). All mouse strains used have been
published previously and were obtained from Jackson
Laboratories (Bar Harbor, ME).12,20,21shRNA Knockdown Cell Lines
Mission pLKO.1-puromycin–resistant lentiviral plasmids
were obtained from Sigma-Aldrich (St. Louis, MO) for gener-
ating shRNA knockdown lines (see Supplementary Table 1 for
The RNAi Consortium Number clone numbers). Uncon-
centrated lentiviral supernatants were generated by the
University of Michigan Viral Vector Core (available from:
http://medicine.umich.edu/medschool/research/ofﬁce-research/
biomedical-research-core-facilities/vector). To generate knock-
down cell lines, hESCs were dissociated into single cells using
Accutase (Sigma-Aldrich). Cells were spun down brieﬂy and
resuspended in mTesR1 plus 10 umol/L Y-27632 (both from
Stem Cell Technologies). Cells (1  106) were infected with
pooled lentivirus by mixing 3 different shRNA viralFigure 1. (See previous page). LGR5 is up-regulated in hPSC
of expression in DE relative to undifferentiated hESC is plotted
test evaluating the difference in expression between the 2 grou
plotted in blue. The 20 most highly up-regulated genes in DE ar
kilobase of transcript per million mapped reads of a subset of g
against the mean FPKM in hES cells (Y-axis). A dashed grey line
left indicating relatively greater expression in DE or hES, resp
transformed P value are given as the color and size of the p
differentially regulated genes are labeled. (C) qRT-PCR showing
differentiated stem cells (red circles) or in DE (green triangles). St
(green bars) and unpaired t test (black bar). (D and E) Re-analysi
LGR5 and (E) RSPO3 loci in undifferentiated hESCs and hESCs
same loci in ESCs and DE.36 ****P  .0001.supernatants for the same target gene. Y-27632 was included
for the ﬁrst 24 hours after dissociation, and media was
changed daily. After 72 hours, cells were selected by puro-
mycin (3 ug/mL) to generate LGR4 and/or LGR5 knockdown
cell lines. For double-knockdown lines, the LGR5 knockdown
line was infected sequentially by pooled LGR4 shRNA.Lineage Tracing
Lgr5-GFP-IRES-CreERT2;Rosa26LacZ and Lgr5-GFP-IRES-
CreERT2;Rosa26tdTomato embryos were generated for lineage
tracing from embryonic stages. Pregnant mice were given
tamoxifen by oral gavage (100mg/kg) at embryonic stages of
E8.5, E10.5, E12.5, and E14.5. For embryonic lineage tracing,
whole gastrointestinal tracts were dissected at E16.5 and
tissues were ﬁxed in 4% paraformaldehyde in phosphate-
buffered saline overnight. X-gal staining was performed the
next day as previously described.22 Whole-mount tissues
were cleared using Murray’s clear before imaging. For line-
age tracing induced in embryos and analyzed at adult stages,
whole gastrointestinal tracts were dissected from 6-week-
old mice and were ﬁxed in 4% paraformaldehyde in
phosphate-buffered saline for 2 hours followed by optimum
cutting temperature embedding for histologic analysis.Differentiation of hESCs
Differentiation of hESCs was performed as previously
published.23–27 In brief, hESCs were grown in feeder-free
conditions on Matrigel (Corning, NY) with mTesrR1 me-
dium (Stem Cell Technologies, Vancouver, BC, Canada),
passaged into 24-well plates, and grown to approximately
70% conﬂuency. Media then was changed to RPMI1640
media plus Activin A (ACTA) (100 ng/mL; R&D Systems,
Minneapolis, MN) for 1 day. The same media was used on
days 2 and 3 of differentiation, except that 0.2% and 2%
fetal bovine serum (HyClone, GE Life Sciences, Logan, UT)
was added on the respective days. For induction of caudal
type homeobox2 (CDX2), endoderm was treated for 4 days
with RPMI1640 with 2% fetal bovine serum (HyClone) and
supplemented with ﬁbroblast growth factor 4 (500 ng/mL),
generated as previously described,28 plus 2 umol/L
Chir99021 (Tocris Bioscience, Bristol, United Kingdom).
Media was changed daily. For organoid experiments,
spheroids that had formed on day 4 of CDX2 induction were
transferred to a droplet of Matrigel and grown in advanced
Dulbecco’s modiﬁed Eagle medium/F12 supplemented with
1 B27 (Thermo Fisher, Waltham, MA), epidermal growth-derived deﬁnitive endoderm. (A) The log2-transformed ratio
against the -log10-transformed P value of a 2-tailed Student t
ps (volcano plot). Genes that differ signiﬁcantly (P < .05) are
e highlighted in red and labeled. (B) The mean fragments per
enes involved in WNT signaling is plotted for the DE (X-axis)
represents equivalent expression, with deviation to the right or
ectively. The log2-transformed expression ratio and -log10-
oints, respectively, as indicated in the legend. The top 20
expression (arbitrary units) of LGR and RSPO mRNA in un-
atistical tests used were as follows: 1-way analysis of variance
s of published LEF1 and b-catenin ChIPseq analysis at the (D)
treated with WNT3A35 and H3K27ac ChIPseq analysis at the
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conditioned medium),29 and R-Spondin2 (5% conditioned
medium).30 Media was changed every 3–4 days.
Histology and Immunoﬂuorescence
Immunoﬂuorescence was performed as previously pub-
lished22,25,31 using antibodies outlined in Supplementary
Table 2. Immunoﬂuorescent images were optimized for
contrast and brightness in a uniform manner, consistent
with the policies of Cellular and Molecular Gastroenterology
and Hepatology.
Cell Sorting and Cell Counting
Forcell countingdatapresented inFigure2BandC,H9-LGR5-
eGFP hESCs were differentiated into endoderm or CDX2þmid/
hindgut.32,33 Monolayers were digested to single cells using
Accutase, spun down, resuspended, and sorted for GFPþ cells.
These cells then were plated for 24 hours and immunostaining
was performed. After staining, the total cell number (40,6-
diamidino-2-phenylindole–positive) and FOXA2þ/SOX17þ
(FOXA2: Forkhead Box A2; SOX17: SRY Box 17) or FOXA2þ/
CDX2þ cells were counted using MetaMorph Software (Molec-
ular Devices, Sunnyvale, CA), as described previously.34
Quantitative Reverse-Transcription
Polymerase Chain Reaction
Brieﬂy, RNA isolation was performed using the MagMAX-
96 total RNA isolation kit (AM1830; Ambion, Waltham, MA).
SuperScript VILO complementary DNA synthesis kit
(11754250; ThermoFisher) was used to make complemen-
tary DNA from 200 ng RNA. Complementary DNA levels
were detected using QuantiTect SYBR Green (608056;
Qiagen). Relative gene expression was plotted as arbitrary
units, using the following formula: [2^(housekeeping gene
Ct - gene Ct)]  10,000. All primer sequences are listed in
Supplementary Table 3. The Ct values for all of the quanti-
tative reverse-transcription polymerase chain reaction (qRT-
PCR) experiments are provided in Supplementary Table 4.Figure 2. (See previous page). LGR5 expression in the hu
h9–LGR5–eGFP reporter hESC line showing GFP expression in
grown for 21 days in vitro, but not in undifferentiated hESCs. (B)
and stained for FOXA2 (red), SOX17 (green), and DAPI (blue). (C)
co-expressing both markers after 24 hours of replating were
endoderm, replated for 24 hours, and stained for FOXA2 (red), CD
expressing FOXA2, CDX2, or co-expressing both markers after
mRNA abundance of LGR genes in mid/hindgut and organoids g
days). (G) qRT-PCR showing mRNA abundance of LGR genes in
replicate per time point). (H) qRT-PCR showing mRNA abundan
of gestation (n  3 replicates per time point). (F–H) One-way an
hybridization (using the RNAscope hybridization system, Adva
denum at 14 weeks of gestation showing strong localization t
matoxylin. (J) GFP expression from Lgr5–eGFP–ires–creER kno
together) showing strong anterior and posterior endoderm exp
through the E14.5 and E16.5 distal small intestine. (K) Lineage t
with tamoxifen given at E8.5, and embryos harvested at E16.5 s
(p) and stomach (s) (arrowheads) in the left panel, and labeling in
Lineage tracing from Lgr5–eGFP–ires–creER;Rosa26–tdTomato
at 6 weeks old, showing lineage labeling in the ileum. Scale bars:
.01, and ***P  .001.Cell Quantiﬁcation and Statistical Analysis
Cell quantiﬁcation was conducted as previously
described in detail.23,34 For statistical analysis, data are
expressed as the median of each sample set, with each data
point represented in the plots. As noted in the ﬁgure legends,
unpaired t tests and 1-way and 2-way analysis of variance
comparisons were performed with GraphPad Prism 5.0
software (GraphPad Software, LaJolla, CA) and data are
presented as the means ± SEM. All animal experiments were
repeated on at least 3 different embryos or adult animals
with representative images shown, and all in vitro experi-
ments were conducted on at least 3 independent biological
replicates, and each experiment was repeated on at least 2
separate occasions (independent experiments). The only
exception to this was the experiments using human tissues.
For these experiments, each stage was represented by only 1
(n ¼ 1) biological sample. For qRT-PCR, the intestine (n ¼ 1
biological sample per time point) was divided into 1-cm
sections and RNA was isolated from at least 3 different seg-
ments (n¼ 3). Each segment was counted as an independent
sample in an analysis shown in Figure 2G.
RNA and ChIP Sequencing
Processing of RNAseq data was conducted as described.23
The complete sequence alignment and expression analysis
scripts can be found at https://github.com/hilldr/Tsai_LGR5_
endoderm_2015. For re-analysis of b-catenin and LEF1 and
H3k27ac ChIPseqdata, public Fastq sequences35werealigned
(hg18) using Bowtie (v1.1.1). Bam ﬁles were reads per kilo-
base of transcript permillionmapped reads normalized using
BamCoverage to generate BigWig ﬁles. Bigwig ﬁles were
visualized using integrative genomics viewer.
Accession Numbers
RNAseq data have been published previously,23,34 and
FastQ ﬁles can be found at the European Molecular Biology
Laboratory-European Bioinformatics Institute ArrayExpress:
E-MTAB-3158. ChIPseq data have been published previ-
ously35,36 and data can be found at Gene Expression
Omnibus: GSE64758 and GSE54471.man and mouse endoderm and intestinal lineages. (A)
endoderm, mid/hindgut, and in human intestinal organoids
GFPHI cells were sorted from endoderm, replated for 24 hours,
The percentage of GFPHI cells expressing FOXA2, SOX17, or
calculated. (D) GFPHI cells were sorted from mid/hindgut
X2 (green), and DAPI (blue). (E) The percentage of GFPHI cells
24 hours of replating were calculated. (F) qRT-PCR showing
rown in vitro for different lengths of time (14 days, 21 days, 28
the human fetal intestine at different weeks of gestation (n¼ 1
ce of Lgr genes in the mouse fetal intestine at different weeks
alysis of variance was used for comparisons. (I) LGR5 in situ
nced Cell Diagnostics, Newark, CA) in the human fetal duo-
o the intervillus domain. Tissue was counterstained with he-
ck-in mouse at E8.5 (whole mount stain, 2 images stitched
ression (arrowhead and arrow, respectively), and in sections
racing from Lgr5–eGFP–IRES–creER;Rosa26–LacZ embryos,
howing lineage labeling (X-gal staining, blue) in the pancreas
the ileum (arrow) and colon (arrowhead) in the right panel. (L)
embryos, with tamoxifen given at E8.5, and tissues analyzed
200 mm. DAPI, 4’,6-diamidino-2-phenylindole. *P  .05, **P 
September 2016 LGR4 and LGR5 in Endoderm Differentiation 653
654 Tsai et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 5Results
LGR5 Is Highly Induced in Deﬁnitive
Endoderm Derived From hESCs
By using publically available RNAseq data generated
from the H9 hESC line and H9 DE (EMBL-EBI ArrayExpress
accession E-MTAB-3158),23,34 we used differential expres-
sion analysis to identify the most highly up-regulated genes
in DE. We observed that LGR5 was among the most highly
up-regulated genes in the DE gene signature (Figure 1A and
Supplementary Table 5). In addition, because LGR receptors
are known to bind RSPO proteins and potentiate WNT
signaling, we examined other differentially expressed
members of the WNT signaling pathway, including ligands,
receptors, modiﬁers, and inhibitors. We found that among a
curated list of Wnt signaling components, LGR5 and RSPO3
were highly induced in DE (Figure 1B and Supplementary
Table 6).
To corroborate the RNAseq data, we used qRT-PCR to
examine the expression of LGR4–6 and RSPO1–3 in undif-
ferentiated hESCs, as well as in hESC-derived DE. We found
that LGR4 was expressed in both hESCs and DE, whereas
LGR6 was almost undetectable. We observed that only LGR5
was highly induced in endoderm (Figure 1C). Furthermore,
RSPO1 was expressed at very low levels, RSPO2 was
expressed in both hESCs and DE, and RSPO3 was almost
undetectable in hESCs, but was highly induced in DE
(Figure 1C).
Because Lgr5 is a known Wnt signaling target gene in
different contexts,12,37 we examined publicly available
b-catenin, LEF1, and H3K27ac ChIPseq data during hESC
differentiation to determine transcription factor binding and
enhancer activity at the LGR5 and RSPO3 loci.35,36 Consistent
with our RNAseq data, H3K27ac levels were increased
within the 180-kb region surrounding the LGR5 locus after
DE induction, supporting the notion that LGR5 transcrip-
tional activity increases after DE induction. hESCs treated
with Wnt3A for 6 hours showed rapid binding of b-cateninFigure 3. (See previous page). RSPO potentiates WNT signa
after 3 days of ACTA (left panel) shows robust FOXA2 (red)
IWP2–treated cells show no FOXA2 or SOX17 (middle and right
panels. (B) Schematic of experimental set-up is shown on the
abundance in all samples for FOXA2, SOX17, and LGR5. All 3
expression is inhibited by IWP2 (3d ACTA þ IWP2). One-wa
Schematic of experimental set-up is shown on the left, along
FOXA2, SOX17, and LGR5 shows that all 3 of these genes
expression is reduced signiﬁcantly by IWP2 (3d ACTA þ 2d A
statistical analysis. (D) Schematic of experimental set-up is sh
mRNA abundance in all samples for FOXA2, SOX17, AXIN2, an
transcripts (compare red triangles with green triangles), and that
in a dose-dependent manner at 10, 50, and 500 ng/mL. Addition
of the IWP2 effect such that gene expression for FOXA2, SOX17
ng/mL along with LGR5 at 10 ng/mL compared with low doses
yellow circle with yellow star). One-way analysis of variance was
with mRNA abundance (y-axis) at different doses of WNT3A (x
IWP2 þ WNT3A þ RSPO1 (red line). An unpaired t test was us
and SOX17 (green) on ACTA þ IWP2–treated hESCs treated
increasing doses of WNT3A, and a constant dose of RSPO1 (
treatment alone does not overcome the effect of IWP2 on ACTA
**P  .01, ***P  .001, and ****P  .0001. All scale bars represand LEF1 to the LGR5 locus as well, indicating that LGR5 is a
direct target of these transcription factors (Figure 1D).
Interestingly, b-catenin and LEF1 were not similarly
recruited to the RSPO3 locus when comparing undifferen-
tiated hESCs with DE, whereas H3K27ac was increased only
modestly. In contrast, AXIN2, a well-characterized WNT
signaling target gene (used here as a positive control),
showed increased binding of b-catenin and enhanced
H3K27ac in response to Wnt3a (Figure 1E). Together, the
results presented in Figure 1 show that LGR5 and RSPO3 are
increased during human DE differentiation, and that these
genes are bound directly by b-catenin and LEF1 upon WNT
stimulation.
LGR5 Is Expressed Across Development in
Human and Mouse Endoderm Lineages
Our ﬁndings show that LGR5 is expressed early during
endoderm differentiation from human ES cells. To deter-
mine if LGR5 is expressed at other stages of intestinal
development/differentiation in human tissue, we took
advantage of a previously described bacterial artiﬁcal
chromosome transgenic H9 LGR5-eGFP hESC reporter
line,24,38 as well as a human intestinal organoid culture
system that recapitulates intestine development
in vitro.25,39 Our results show that eGFP was undetectable
in hESCs, whereas eGFP was abundant in endoderm,
hindgut, and organoids (Figure 2A). To verify that LGR5-
eGFP–positive cells indeed were enriched for endoderm
lineages, we used ﬂuorescence-activated cell sorting to
purify GFPHI cells from DE cultures (Figure 2B) or mid/
hindgut cultures (Figure 2D), replated them for 12 hours,
and used immunoﬂuorescence to co-stain endoderm for
SOX17 and FOXA2 (Figure 2B) or mid/hindgut for FOXA2
and CDX2 (Figure 2D). Quantiﬁcation of co-stained cells
showed that approximately 85% of GFPHI endoderm
stained positive for FOXA2 and approximately 75% stained
positive for SOX17 or co-stained for both FOXA2 andling during endoderm differentiation. (A) hESC-derived DE
and SOX17 (green) staining. In contrast, IWP2- or ACTA þ
panels, respectively). Nuclei are marked by DAPI (blue) in all
left, along with a sample legend. qRT-PCR showing mRNA
of these genes are induced robustly in DE (3d ACTA), and
y analysis of variance was used for statistical analysis. (C)
with a sample legend. mRNA abundance in all samples for
are induced robustly in DE (5d ACTA), and that endoderm
CTA þ IWP2). One-way analysis of variance was used for
own on top, along with a sample legend. qRT-PCR showing
d LGR5. Data show that IWP2 blocks ACTA induction of all 4
addition of exogenous WNT3A ligand rescues the IWP2 effect
of exogenous RSPO1 (500 ng/mL) potentiates WNT3A rescue
, and AXIN2 is enhanced signiﬁcantly in RSPO þWNT3A at 2
of WNT3A alone (compare purple circle with purple star, and
used for statistical analysis. (E) Data shown in panel D plotted
-axis) for ACTA þ IWP2 þ WNT3A (green line) and ACTA þ
ed for statistical analysis. (F) Immunostaining for FOXA2 (red)
with increasing doses of exogenous WNT3A (top row) or
500 ng/mL) (bottom row). (G) Controls to show that RSPO1
-treated cells. DAPI, 4’,6-diamidino-2-phenylindole. *P  .05,
ent 200 mm.
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cells were positive for FOXA2 or CDX2 and approximately
72% were positive for both markers (Figure 2E).
To corroborate our ﬁndings with the bacterial artiﬁcal
chromosome transgenic H9 LGR5-eGFP hESC reporter line,
we conducted qRT-PCR at different stages of hESC-
differentiated intestinal tissue, including the mid/hindgut
stage, and in organoids after days 14, 21, and 28 in vitro. We
found that LGR4 was expressed at similar levels across these
stages, that LGR6 expression was undetectable, and that
LGR5 expression was highest at the hindgut stage, but was
maintained at all organoid stages examined (Figure 2F).
Similarly, we examined human fetal intestinal tissue by qRT-Figure 4. LGR4 and LGR5 are required for endoderm diffe
samples for LGR4, LGR5, FOXA2, and SOX17. h9–shRNA–s
knockdown, and h9–shRNA–LGR4/5 knockdown lines all were
One-way analysis of variance was used for statistical analys
h9–shRNA–LGR5 knockdown, and h9–shRNA–LGR4/5 knockd
endoderm formation, and immunostained for FOXA2 (red) and S
represent 200 mm. (C) Cell staining shown in panel B was quant
FOXA2þ cells (red), the percentage of SOX17þ cells (green), and
using 1-way analysis of variance. Dissimilar letters in a speciﬁc
whereas similar letters in a color group indicate no difference
***P  .001, and ****P  .0001.PCR at 11, 14, and 15 weeks of gestation (n ¼ 1 biological
replicate per time point), and we found that LGR4
messenger RNA (mRNA) was expressed at low levels at all
stages, that LGR5 was the most highly expressed LGR family
member, and that LGR6 was undetectable (Figure 2G). The
expression of LGR5 was conﬁrmed by in situ hybridization
on sections at 14 weeks of development (Figure 2I). Inter-
estingly, when we examined expression of Lgr4, 5, and 6 in
the developing mouse intestine at 15.5, 16.5, 17.5, and 18.5
days of gestation, qRT-PCR results consistently showed that
Lgr4 and Lgr6 had more abundant levels of transcript
relative to Lgr5, highlighting gene expression differences
between human beings and mice (Figure 2H).rentiation. (A) qRT-PCR showing mRNA abundance in all
crambled, h9–shRNA–LGR4 knockdown, h9–shRNA–LGR5
treated for 3 days with ACTA to induce endoderm formation.
is. (B) h9–shRNA–scrambled, h9–shRNA–LGR4 knockdown,
own lines all were treated for 3 days with ACTA to induce
OX17 (green). Nuclei were stained with DAPI (blue). Scale bars
itated. Each color group, corresponding to the percentage of
the percentage of double-positive cells (blue) was compared
color group indicate signiﬁcantly different values (P  .05),
. DAPI, 4’,6-diamidino-2-phenylindole. *P  .05, **P  .01,
Figure 5. b-catenin stabilization rescues loss of LGR4 or LGR5 knockdown. (A) qRT-PCR showing mRNA abundance in all
samples for FOXA2, SOX17, and LGR5. h9–shRNA–scrambled, h9–shRNA–LGR4 knockdown, h9–shRNA–LGR5 knockdown,
andh9–shRNA–LGR4/5knockdown linesallwere treated for3dayswithACTA,orwithACTAþ1umol/LChir99021 (Chir) to induce
endoderm formation. LGR4, 5, and 4/5 knockdown lines treated with Chir showed a statistically signiﬁcant rescue of expression
levels for all genes inall knockdown lines, except forAXIN2 in theLGR4knockdown line.One-wayanalysisof variancewasused for
statistical analysis across groups. (B) h9–shRNA–scrambled, h9–shRNA–LGR4 knockdown, h9–shRNA–LGR5 knockdown, and
h9–shRNA–LGR4/5knockdown lines allwere treated for 3dayswithACTA to induceendoderm formationorwithACTAþ 1umol/L
Chir, and immunostained for FOXA2 (red) and SOX17 (green). Nuclei were stained with DAPI (blue). Scale bars represent 200 mm.
(C) Cell staining shown in panel Bwas quantitated. Each color group, corresponding to the percentage of FOXA2þ cells (red), the
percentage of SOX17þ cells (green), and the percentage of double-positive cells (blue) was compared using 1-way analysis of
variance. Statistical comparisons were performed between a particular knockdown group and the corresponding Chir-treated
group (ie, the percentage of FOXA2-positive in shRNA-LGR5 vs shRNA–LGR5þ Chir, and so forth). Dissimilar labels in a color
groupdenote statistically signiﬁcantdifferences (ie, 5a vs5b) (P .05),whereassimilar labels in acolor group indicatenodifference
(ie, Sa vs Sa). DAPI, 4’,6-diamidino-2-phenylindole. *P  .05, **P  .01, ***P  .001, and ****P  .0001.
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September 2016 LGR4 and LGR5 in Endoderm Differentiation 657Lgr5 Is Expressed in Deﬁnitive Endoderm in Mice
To determine if earlier endodermal Lgr5 expression is
conserved between humans and mice, and to show that
endodermal expression is detectable in an in vivo animal
model, we used Lgr5-GFP-IRES-CreERT2 mice, in whichGFP faithfully reports Lgr5 expression in many different
contexts.12,40,41 By using whole-mount immunoﬂuores-
cence in E8.5 embryos co-stained for Sox17 and GFP, we
observed staining for GFP in the anterior foregut endoderm
(Figure 2J, arrowhead), as well as in Sox17þ hindgut
658 Tsai et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 5endoderm (Figure 2J, arrow) (note that 2 images were
stitched together to generate the E8.5 image in Figure 2J).
Examining Lgr5-driven GFP expression across time in the
developing mouse intestine, we also observed GFP at E14.5
and E16.5. Consistent with our data, Lgr5-GFP recently was
reported in the developing mouse intestine at E12.5.42 We
conducted lineage tracing at several different develop-
mental times to determine if early embryonic Lgr5þ cells
contribute to adult tissues (Figure 2K and L, and
Supplementary Figures 1 and 2). Lineage labeling was
induced in timed pregnant Lgr5-GFP-IRES-CreERT2 female
mice crossed to Rosa26–LSL–LacZ or Rosa–
LSL–tdTomato mice at 8.5 days of gestation. Lineage-
labeled embryos were harvested at E16.5 (Figure 2K) or
at 6 weeks old (Figure 2L). We observed small patches of
lineage labeling in the pancreas, stomach, and intestine at
E16.5, and labeling that persisted into adulthood
(Figure 2K). It is likely that recombination efﬁciencies in
our experiments were poor given that lower doses of
tamoxifen were administered by oral gavage to avoid
miscarriage at early stages. Similarly, embryos given
tamoxifen at later time points (E10.5, E12.5, E14.5) showed
embryonic and adult labeling, however, the contribution of
Lgr5 lineage-labeled cells in the pancreas and stomach
decreased over time, whereas intestinal labeling increased
over time (Supplementary Figures 1 and 2). Similarly, the
contribution of Lgr5 lineage-labeled cells to the adult in-
testinal lineage increased over time (Supplementary
Figure 2). Together, these results show that E8.5 endo-
derm expresses Lgr5, that cells expressing Lgr5 are found
across development, and that Lgr5þ progenitor cells
labeled at all embryonic times examined (E8.5–E16.5)
contribute to the adult intestinal epithelium.R-Spondin Proteins Potentiate WNT Signaling
During DE Differentiation
Our studies used well-described methods to generate DE
using ACTA, but not WNT ligands.25,26 However, Wnt
signaling plays an important role in the commitment to the
endoderm lineage both in vitro and in vivo.43–49 Therefore,
we wanted to determine the following: (1) if WNT signaling
was required during our ACTA differentiation protocol; (2)
if inhibition of WNT signaling led to decreased LGR5Figure 6. (See previous page). Exogenous RSPO1 rescues
abundance in all samples for FOXA2, SOX17, and AXI
h9–shRNA–LGR5 knockdown, and h9–shRNA–LGR4/5 knockdo
RSPO1 (500 ng/mL) to induce endoderm formation. LGR4, 5, a
tistically signiﬁcant rescue of expression levels for all genes in a
line. One-way analysis of variance was used for statis
h9–shRNA–LGR4 knockdown, h9–shRNA–LGR5 knockdown, a
days with ACTA to induce endoderm formation or with ACTA
(green). Nuclei were stained with DAPI (blue). Scale bars represe
Each color group, corresponding to the percentage of FOXA2þ
percentage of double-positive cells (blue) was compared usin
performed between a particular knockdown group and the corre
positive in shRNA–LGR5 vs shRNA–LGR5 þ RSPO1, and so
signiﬁcant differences (ie, 5a vs 5b) (P  .05), whereas similar lab
4’,6-diamidino-2-phenylindole. *P  .05, **P  .01, ***P  .001expression; and (3) if RSPO/LGR signaling potentiated WNT
signaling during endoderm differentiation. To determine if
DE induced by ACTA requires WNT signaling, we added
ACTA to hESC cultures with and without inhibitor of WNT
processing 2 (IWP2), a small molecule that inhibits Porcu-
pine, leading to disrupted processing and inhibition of
endogenous WNT ligand secretion from cells.50 We found
that inclusion of IWP2 during ACTA-induced DE differenti-
ation almost completely abolished the induction of FOXA2/
SOX17þ cells (Figure 3A). Similarly, ACTA-stimulated in-
duction of FOXA2, SOX17, and LGR5 mRNA was blocked
completely by addition of IWP2 during differentiation
(Figure 3B). These experiments (Figure 3A and B) inhibited
WNT signaling at the onset of differentiation. To determine
if WNT signaling is required for LGR5 expression after DE
induction, we treated hESCs with ACTA for 3 days to induce
DE, and then cultured cells for an additional 2 days with
ACTA ± IWP2 (Figure 3C). The results showed that DE
treated with IWP2 had reduced LGR5 levels, suggesting that
sustained WNT signaling is required for expression of these
genes (Figure 3C), and supporting b-catenin and LEF1
ChIPseq data (Figure 1D and E) showing that LGR5 is a WNT
target gene.
Finally, we asked if RSPO/LGR signaling synergized with
WNT signaling during endoderm induction. For this exper-
iment, we took advantage of the fact that IWP2 abolished
the ability of ACTA to induce DE (Figure 3A and B), and we
rescued WNT signaling by adding increasing doses (2, 10,
50, 500 ng/mL) of exogenous WNT3A ± RSPO1 (500 ng/
mL) (Figure 3D–F). Importantly, high doses of RSPO1 (500
ng/mL) alone did not rescue IWP2-inhibited DE induction,
indicating that in the absence of WNT ligand, RSPO1 does
not have a role in this process (Figure 3G). We hypothesized
that if RSPO/LGR potentiates WNT signaling during DE
differentiation, that low doses of WNT3A plus RSPO1 should
have more efﬁcient DE induction compared with WNT3A
alone. Indeed, we observed that ACTA þ IWP2 plus low
doses of WNT3A (2 or 10 ng/mL) resulted in minimal DE
induction as measured by FOXA2 and SOX17 mRNA
(Figure 3D and E) and immunoﬂuorescence (Figure 3F),
whereas low doses of WNT3A (2, 10 ng/mL) plus RSPO1
resulted in signiﬁcantly higher levels of FOXA2 and SOX17
mRNA and noticeably more positively stained cells
(Figure 3D–F). Moreover, at low doses of WNT3A,loss of LGR4 or LGR5 knockdown. (A) qRT-PCR mRNA
N2. h9–shRNA–scrambled, h9–shRNA–LGR4 knockdown,
wn lines all were treated for 3 days with ACTA, or with ACTA þ
nd 4/5 knockdown lines treated with RSPO1 showed a sta-
ll knockdown lines, except for AXIN2 in the LGR4 knockdown
tical analysis across groups. (B) h9–shRNA–scrambled,
nd h9–shRNA–LGR4/5 knockdown lines all were treated for 3
þ RSPO1, and immunostained for FOXA2 (red) and SOX17
nt 200 mm. (C) Cell staining shown in panel B was quantitated.
cells (red), the percentage of SOX17þ cells (green), and the
g 1-way analysis of variance. Statistical comparisons were
sponding RSPO1-treated group (ie, the percentage of FOXA2-
forth). Dissimilar labels in a color group denote statistically
els in a color group indicate no difference (ie, Sa vs Sa). DAPI,
, and ****P  .0001.
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increased when comparing ACTA þ IWP2 þ WNT3A vs
ACTA þ IWP2 þ WNT3A þ RSPO1 (Figure 3D and E). The
synergistic effect of WNT3A þ RSPO1 was apparent only at
low doses and was lost when exogenous WNT3A exceeded
50 ng/mL (Figure 3E). Based on this data, we conclude that
ACTA-stimulated DE differentiation requires WNT signaling,
and that RSPO proteins act to potentiate WNT signaling
during this process.
LGR4 and LGR5 Are Functionally Required
for Human Endoderm Differentiation
Because LGR4 and LGR5 are expressed in hESC-derived
endoderm, hindgut, and intestinal organoids, as well as in
the human fetal intestine (Figures 1–3), we wanted to
determine if LGR4 and 5 are functionally required for dif-
ferentiation. To do this, we used lentiviral shRNAs to
generate a control (scrambled shRNA) H9 hES cell line and
to generate LGR4–shRNA, LGR5–shRNA, and LGR4/
5–shRNA knockdown lines. To determine the efﬁciency of
knockdown, we differentiated all cell lines into DE, and
performed qRT-PCR for LGR4 and LGR5 (Figure 4A). Inter-
estingly, in LGR4–shRNA and LGR5–shRNA knockdown
lines, we observed a signiﬁcant reduction in both receptors
for each line (Figure 4A). This observation likely is
explained by the reduced efﬁciency of endoderm induction
in any of the knockdown lines (Figure 4A and B). Double
knockdown showed a signiﬁcant reduction in both tran-
scripts (Figure 4A).
To assess the consequences of LGR knockdown, we
generated DE from scrambled control and knockdown
lines, and performed qRT-PCR (Figure 4A) and immuno-
ﬂuorescence for FOXA2/SOX17 (Figure 4B and C).
LGR4–shRNA and LGR5–shRNA knockdown lines showed
signiﬁcantly reduced FOXA2 and SOX17 expression
compared with control, and LGR4/5–shRNA double
knockdown showed an even larger reduction in these
transcripts (Figure 4A). qRT-PCR results were supported
by immunoﬂuorescence staining for FOXA2 and SOX17
(Figure 4B and C), which showed a robust and signiﬁcant
reduction in co-staining, indicating that DE differentiation
was impaired in knockdown lines. The reduction in the
number of cells stained for FOXA2, SOX17, or for both
proteins was statistically reduced in all 3 knockdown lines
compared with controls (Figure 4C).
Differentiation Potential of LGR4 and/or
LGR5 Knockdown Cell Lines
Given that knockdown of LGR4, LGR5, and LGR4/5
resulted in poor endoderm formation compared with
the scrambled control, we wanted to determine the fate
of these cells after 3 days of exposure to ACTA
(Supplementary Figure 3A). LGR4/5 knockdown cells
showed signiﬁcantly higher levels of neural markers PAX6
and NESTIN and the mesodermal lineage marker T
(encoding the protein BRACHYURY), indicating that these
cultures are enriched with neural and mesenchymal line-
ages (Supplementary Figure 3A and B).Stabilization of b-Catenin Downstream of
Ligand-Receptor Interactions Rescues DE
Differentiation With Lgr4 and Lgr5 Knockdown
Given that RSPO/LGR interacts with WNT signaling at
the cell surface, and knockdown of LGR4 and/or LGR5 leads
to reduced DE formation (Figure 4), we hypothesized that
stabilization of b-catenin downstream of ligand/receptor
complexes should rescue endoderm induction in LGR shRNA
knockdown hESC lines. To do this, we used Chir99021, a
potent and speciﬁc GSK3b inhibitor involved in the b-cat-
enin destruction complex, such that inhibition of GSK3b
with Chir99021 allows b-catenin stabilization downstream
of ligand/receptors.11,51,52 We differentiated all 4 hESC
lines (control, knockdown) using a 3-day ACTA protocol
along with dimethyl sulfoxide (control) or with Chir99021
(1 umol/L) (Figure 5). qRT-PCR (Figure 5A) and immuno-
ﬂuorescence (Figure 5B and C) showed that Chir99021 was
able to rescue the defective endoderm differentiation
observed in LGR4, LGR5, and LGR4/5 shRNA knockdown
both at the gene expression and cellular level. Our results
also showed that addition of Chir99021 led to a rescue in
the mRNA expression level of the WNT/b-catenin target
gene AXIN2 (Figure 5A). We also conducted rescue experi-
ments with higher doses of Chir99021 (2 umol/L) and
observed that this dose showed similar results to the lower
dose (Supplementary Figure 4).
Exogenous RSPO1 Rescues DE Differentiation
in LGR4 and LGR5 Knockdown hESC Lines
Because shRNAs reduce, but do not completely inhibit,
gene expression, and because LGR receptors function
redundantly, we reasoned that it also may be possible to
rescue DE induction in knockdown lines by adding exoge-
nous RSPO proteins because the current differentiation
paradigm relies on endogenous RSPO production. Therefore,
we added RSPO1 (500 ng/mL) throughout the differentia-
tion (3 days of ACTA þ RSPO1) and assayed DE induction
with qRT-PCR and immunoﬂuorescence (Figure 6). qRT-
PCR showed that mRNA levels of FOXA2 and SOX17 signif-
icantly were restored when RSPO1 was added for 3 days
(Figure 6A). In LGR4 and LGR5 knockdown lines, addition of
RSPO1 for 3 days led to a statistically signiﬁcant increase in
SOX17 and FOXA2, however, AXIN2 mRNA expression was
rescued in the LGR4 knockdown and LGR4/5 double-
knockdown line, but not in the LGR5 knockdown group
(Figure 6A). Consistent with mRNA data, addition of RSPO1
to cultures during DE induction led to a signiﬁcant rescue of
the number of FOXA2, SOX17, or double-positive DE cells
present in the culture (Figure 6B and C). We also repeated
the earlier-described experiment, but added RSPO1 only on
the ﬁrst day of ACTA treatment, followed by 2 days of ACTA
alone (Supplementary Figure 5). Interestingly, in this
experiment, at the mRNA level, FOXA2 was rescued in all
knockdown lines whereas SOX17 and AXIN2 were rescued
only in the LGR4/5 double-knockdown line. Rescue was
seen at the protein level in all knockdown lines treated with
1 day of RSPO1 during endoderm induction (Supplementary
Figure 5B and C).
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Wnt signaling is known to have important roles in
regulating pluripotency53,54 and endoderm differentiation
both in vitro and in vivo,55–57 however, it remains unclear
how the Wnt signal might be tailored to the speciﬁc contexts
of pluripotency vs endoderm. Based on our results, it is
interesting to speculate that LGR4 and LGR5 might function
in stage-dependent contexts to act as a rheostat for WNT
signaling during this transition. Our ﬁndings show that LGR4
is expressed constitutively in hESCs and their differentiated
progeny, whereas LGR5 is induced highly during DE differ-
entiation and is maintained in CDX2þ endoderm derivatives
(Figure 1). Thus, for example, it is possible that LGR4
function is most important during the initial stages of DE
induction to amplify WNT/b-catenin signaling, whereas
LGR5 function is important to maintain high levels of
WNT signaling later during differentiation, however, this
idea has not yet been tested experimentally. In an analogous
manner, Lgr-directed Wnt signaling has been proposed to
work in context-speciﬁc roles in the crypt base columnar
stem cells to direct Achaete-Scute Family BHLH Transcrip-
tion Factor 2-mediated stem cell control.58
Oneﬁndingof the current study showed that inbothmouse
and human systems, LGR5 expression is present at very early
stages of development. Although Lgr5 expression has been
documented in numerous contexts in mice, much less is
known about early developmental contexts, and expression in
developinghuman tissues isparticularly lacking.Other studies
have reported embryonic expression in the early mouse gut
before villus formation,42 and functional studies have sup-
ported the notion that in mice Lgr4 plays a more important
functional role in the embryonic intestine than Lgr5.17–19 Our
data in the developing mouse intestine are consistent with
published studies, indicating that Lgr4 is expressed more
highly than Lgr5. Interestingly, using human intestinal orga-
noid differentiation as a surrogate for human development,
and by examining human fetal intestines, we found that LGR5
consistently was expressed more highly relative to LGR4
across progressive stages of intestine differentiation, and in
the human fetal intestine. Thus, although expression and
function of Lgrs in the mouse are better characterized than in
human beings, our studies suggest that expression differences
between species exist, opening the possibility that functional
differences also may exist. Future studies will be required to
further clarify functional differences between human beings
and mice in light of these ﬁndings.References
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Supplementary
Figure 1. Lgr5–eGFP–
ires–creER–mediated li-
neage tracing across
time. Timed pregnant fe-
males were given tamox-
ifen when embryos were
E10.5 (top row), E12.5
(middle row), or E14.5
(bottom row), and all em-
bryos were collected at
E16.5. E10.5 and E12.5
lineage tracing was evident
in the stomach and intes-
tine, whereas less lineage
tracing was seen in the
stomach and more was
seen in the intestine when
tamoxifen was given at
E14.5. Lineage tracing was
performed with Rosa26–
LacZ and X-gal staining is
shown in blue. Scale bar:
200 mm.
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Supplementary Figure 2. Lgr5–eGFP–ires–creER–mediated lineage tracing from embryo to adult. Timed pregnant fe-
males were given tamoxifen when embryos were E8.5, E12.5, E14.5, or E16.5, and whole intestines were examined using
Swiss rolls in 6-week-old adults so that the proximal (P) and distal (D) intestine could be visualized in one section. Lineage
tracing was performed with Rosa26-tdTomato and lineage tracing is shown in red. Lgr5-eGFP is visualized in green. Increased
lineage labeling can be seen as developmental time progresses. For controls, corn oil was administered to timed pregnant
females (Lgr5–eGFP–ires–creER;Rosa–LSL–Tomato) when embryos were E8.5 or E14.5, and whole intestines were examined
in 6 week old adults via Swiss roll. Corn oil controls showed no lineage labeling. DAPI, 4’,6-diamidino-2-phenylindole; Scale
bars: 200 mm.
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Supplementary Figure 3. Assessment of lineage markers in control, LGR4, LGR5, and LGR4/5 knockdown hESC lines.
h9–shRNA–scrambled, h9–shRNA–LGR4, h9–shRNA–LGR5, and h9–shRNA–LGR4/5 knockdown lines all were treated for 3
days with ACTA to induce endoderm formation. qRT-PCR showing mRNA expression above hESCs for (A) neural markers
PAX6 and NESTIN, and (B) mesenchymal lineage markers BRACHYURY, VIMENTIN, and FOXF1. One-way analysis of vari-
ance was used for statistical analysis. *P  .05, **P  .01, ***P  .001, and ****P  .0001.
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Supplementary Figure 4. (See previous page). b-catenin stabilization rescues loss of LGR4 or LGR5 knockdown. (A)
qRT-PCR showing mRNA expression above hESCs for FOXA2, SOX17, and AXIN2. h9–shRNA–scrambled, h9–shRNA–LGR4
knockdown, h9–shRNA–LGR5 knockdown, and h9–shRNA–LGR4/5 knockdown lines all were treated for 3 days with ACTA, or
with ACTA þ 2 umol/L Chir99021 (Chir) to induce endoderm formation. LGR4, 5, and 4/5 knockdown lines treated with Chir
showed a statistically signiﬁcant rescue of expression levels for all genes in all knockdown lines, except for SOX17 in the LGR5
knockdown line. One-way analysis of variance was used for statistical analysis across groups. (B) h9–shRNA–scrambled,
h9–shRNA–LGR4 knockdown, h9–shRNA–LGR5 knockdown, and h9–shRNA–LGR4/5 knockdown lines all were treated for 3
days with ACTA to induce endoderm formation or with ACTA þ 2 umol/L Chir, and immunostained for FOXA2 (red) and SOX17
(green). Nuclei were stained with DAPI (blue). (C) Cell staining shown in (B) was quantitated. Each color group, corresponding
to %FOXA2þ cells (red), %SOX17þ cells (green), % double positive (blue) was compared using one-way ANOVA. Statistical
comparisons were carried out between a particular knockdown group and the corresponding RSPO1 treated group (ie,
%FOXA2 positive in shRNA-LGR5 vs shRNA-LGR5þRSPO1, etc). Dissimilar labels in a color group denote statistically
signiﬁcant differences (ie, 5a vs 5b) (P  .05), whereas similar labels in a color group indicate no difference (ie, Sa vs Sa).
Dissimilar labels in a color group denote statistically signiﬁcant differences (ie, 5a vs 5b) (P  .05), whereas similar labels in a
color group indicate no difference (ie, Sa vs Sa). DAPI, 4’,6-diamidino-2-phenylindole; DMSO, dimethyl sulfoxide. Scale bars:
200 mm. *P  .05, **P  .01, ***P  .001, and ****P  .0001.
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Supplementary Figure 5. (See previous page). Exogenous RSPO1 rescues loss of LGR4 or LGR5 knockdown. (A) qRT-
PCR showing mRNA expression above hESCs for FOXA2, SOX17, and AXIN2. h9–shRNA–scrambled, h9–shRNA–LGR4
knockdown, h9–shRNA–LGR5 knockdown, and h9–shRNA–LGR4/5 knockdown lines all were treated for 3 days with ACTA, or
with ACTAþRSPO1 (500 ng/mL) on day 1 only, followed by 2 additional days of ACTA to induce endoderm formation. LGR4, 5,
and 4/5 knockdown lines treated with RSPO1 showed a statistically signiﬁcant rescue of expression levels for FOXA2 in all
knockdown lines, whereas only the LGR4/5 knockdown lines showed rescue for SOX17 and AXIN2 gene expression. One-way
analysis of variance was used for statistical analysis across groups. (B) h9–shRNA–scrambled, h9–shRNA–LGR4 knockdown,
h9–shRNA–LGR5 knockdown, and h9–shRNA–LGR4/5 knockdown lines all were treated for 3 days with ACTA to induce
endoderm formation or with ACTAþRSPO1 on day 1, followed by 2 days of ACTA, and immunostained for FOXA2 (red) and
SOX17 (green). Nuclei were stained with DAPI (blue). (C) Cell staining shown in panel B was quantitated. Each color group,
corresponding to the percentage of FOXA2þ cells (red), the percentage of SOX17þ cells (green), and the percentage of
double-positive cells (blue) was compared using 1-way analysis of variance. Statistical comparisons were performed between
a particular knockdown group and the corresponding RSPO1-treated group (ie, the percentage of FOXA2 positive in
shRNA–LGR5 vs shRNA–LGR5þRSPO1, and so forth). Dissimilar labels in a color group denote statistically signiﬁcant dif-
ferences (ie, 5a vs 5b) (P  .05), whereas similar labels in a color group indicate no difference (ie, Sa vs Sa). DAPI, 4’,6-
diamidino-2-phenylindole. Scale bars: 200 mm. *P  .05, **P  .01, ***P  .001, and ****P  .0001.
Supplementary Table 1.shRNA clone identiﬁers
Target genes The RNAi Consortium number
shRNA LGR4 TRCN0000285015
shRNA LGR4 TRCN0000273590
shRNA LGR4 TRCN0000004742
shRNA LGR5 TRCN0000011585
shRNA LGR5 TRCN0000011586
shRNA LGR5 TRCN0000011587
Supplementary Table 2.Antibodies
Antibody Source Dilution
CDX2 MU392A-UC; Bio-Genex (Fremont, CA) 1:500
FOXA2 WRAB 1200; Seven Hill, Cincinnati, OH 1:500
GFP Ab13970; Abcam (Cambridge, MA) 1:500
SOX17 AF 1924; R&D Systems (Minneapolis, MN) 1:500
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Supplementary Table 3.qRT-PCR primers
Gene Sequence
h-AXIN2-F AGTGTGAGGTCCACGGAAAC
h-AXIN2-R CTGGTGCAAAGACATAGCCA
h-BRACHYURY-F GCAAAAGCTTTCCTTGATGC
h-BRACHYURY-R ATGAGGATTTGCAGGTGGAC
h-FOXA2-F CGACTGGAGCAGCTACTATGC
h-FOXA2-R TACGTGTTCATGCCGTTCAT
h-FOXF1-F AGTCCCCAATGCAAAGACAC
h-FOXF1-R TCAGCAGAATTCCTGTGTGG
h-LGR4-F GCCTGAATGGGCTAAATCAA
h-LGR4-R CCTTTCTCCTGTGCCACACT
h-LGR5-F CAGCGTCTTCACCTCCTACC
h-LGR5-R TGGGAATGTATGTCAGAGCG
h-LGR6-F CAAGCCCTGGATCTTAGCTG
h-LGR6-R TTTTGGGAAACTGTCCTTGG
h-NESTIN-F GCCCTGACCACTCCAGTTTA
h-NESTIN-R GGAGTCCTGGATTTCCTTCC
h-OCT4-F GTGGAGGAAGCTGACAACAA
h-OCT4-R GGTTCTCGATACTGGTTCGC
h-PAX6-F GTTGGTATCCGGGGACTTC
h-PAX6-R TCCGTTGGAACTGATGGAGT
h-RSPONDIN 1-F TGATTGGCATGTTACCCAAA
h-RSPONDIN 1-R ACCATCACTGGAAGCCTACG
h-RSPONDIN 2-F GAGCGAATGGGGAACTTGTA
h-RSPONDIN 2-R TCCTCTTCTCCTTCGCCTTT
h-RSPONDIN 3-F GCATCCTTCAGCAAAGGGTA
h-RSPONDIN 3-R TCGTTGCTCTGGGATTTCTT
h-SOX17-F CAGAATCCAGACCTGCACAA
h-SOX17-R TCTGCCTCCTCCACGAAG
h-VIMENTIN-F CTTCAGAGAGAGGAAGCCGA
h-VIMENTIN-R ATTCCACTTTGCGTTCAAGG
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